Additional Details

  • AlloSure Lung Assessment and Metagenomics Outcomes Study

    Montefiore Medical Center
    Bronx NY. 10467
    View Details

  • AlloSure Lung Assessment and Metagenomics Outcomes Study

    Vanderbilt University Medical Center
    Nashville TN. 37232
    View Details

  • AlloSure Lung Assessment and Metagenomics Outcomes Study

    University of Alabama (UAB)
    Birmingham AL. 35233
    View Details

  • AlloSure Lung Assessment and Metagenomics Outcomes Study

    Brigham and Womens Hospital
    Boston MA. 02115
    View Details

  • AlloSure Lung Assessment and Metagenomics Outcomes Study

    Inova
    Falls Church VA. 22042
    View Details

  • AlloSure Lung Assessment and Metagenomics Outcomes Study

    University of Pennsylvania
    Philadelphia PA. 19104
    View Details

  • AlloSure Lung Assessment and Metagenomics Outcomes Study

    Loyola University Medical School
    Maywood IL. 60153
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Temple University
    Philadelphia PA. 19140
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    UPMC - Dorothy P. and Richard P. Simmons Center for Interstitial Lung Diseases (ILD)
    Pittsburgh PA. 15213
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Local Institution - 0455
    Detroit MI. 48202
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Local Institution - 0495
    Saint-Charles-Borromee QC. J6E 2B4
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Monteregie Centre de Recherche
    Greenfield Park QC. J4V 2H1
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Ocala Lung & Critical Care
    Ocala FL. 34471
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    South Texas Veterans Health Care System - Audie L. Murphy VA Hospital
    San Antonio TX. 78229-4404
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    University of Michigan
    Ann Arbor MI. 48109-5000
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    St. Joseph's Healthcare Hamilton
    Hamilton ON. L8N 4A6
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Mercy St. Vincent Medical Center
    Toledo OH. 43608-2603
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Centre Hospitalier de l'Université de Montréal (CHUM)
    Montreal QC. H2X 0C1
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

    Baylor University Medical Center at Dallas
    Dallas TX. 75245-2017
    View Details